退伍军人健康管理局中种族与族裔少数群体的死亡率差异:一项证据综述与图谱
该研究系统检索2006年10月至2017年2月文献,纳入25项大型队列研究,比较退伍军人健康管理局内少数族裔与非少数族裔退伍军人的死亡率。多数研究显示黑人退伍军人死亡率相似或更低,但在慢性肾病4期、结肠癌、糖尿病、HIV、直肠癌、卒中、非心脏大手术及西班牙裔HIV或创伤性脑损伤中仍存在差异。
要点
- 共纳入25项大型、全国代表性队列研究,多数质量中等。
- 黑人退伍军人多数临床领域死亡率相似或更低,但部分领域存在差异。
- 美洲印第安人/阿拉斯加原住民非心脏大手术后死亡率存在差异。
核心结论
- 退伍军人健康管理局的平等就医体系已减少私营部门中许多种族/族裔死亡率差异,但黑人退伍军人在若干临床领域仍存在持续差异。
- 由于多数死亡率差异仅由单项研究支持且结果不精确,无法就此证据得出强结论。
- 需要对美洲印第安人/阿拉斯加原住民、亚裔和西班牙裔退伍军人开展更多差异研究,并关注更多最大预期寿命差距。
研究设计与样本
- 研究为证据综述与图谱,检索MEDLINE和Cochrane对照试验中心注册库,时间范围为2006年10月至2017年2月。
- 纳入标准为比较退伍军人健康管理局内任何种族/族裔少数群体与非少数群体退伍军人或不同少数群体间死亡率的研究(PROSPERO# CRD42015015974)。
- 由两名评价员序贯筛选文献、提取数据,并根据研究局限性、一致性、直接性、精确性和报告偏倚5个关键域分级证据强度。
- 对同一人群和结局的多项研究,采用随机效应模型合并报告的风险比(HR)。
- 从2840篇引文中最终纳入25项研究,研究样本量大(n ≥ 10 000)且涉及全国代表性队列,多数质量中等。
主要发现
- 多数研究比较黑人与白人退伍军人死亡率,发现黑人退伍军人死亡率相似或更低。
- 黑人退伍军人在慢性肾病4期、结肠癌、糖尿病、HIV、直肠癌或卒中中,死亡率差异的HR或OR = 1.07、1.52(多数证据强度低)。
- 美洲印第安人/阿拉斯加原住民退伍军人接受非心脏大手术后存在死亡率差异(多数证据强度低)。
- 西班牙裔退伍军人合并HIV或创伤性脑损伤时存在死亡率差异(多数证据强度低)。
关键数值与推荐
- 黑人退伍军人在慢性肾病4期、结肠癌、糖尿病、HIV、直肠癌或卒中中,HR或OR = 1.07、1.52(多数低强度证据)。
- 美洲印第安人/阿拉斯加原住民退伍军人非心脏大手术后存在死亡率差异(多数低强度证据)。
- 西班牙裔退伍军人合并HIV或创伤性脑损伤时存在死亡率差异(多数低强度证据)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 多数死亡率差异仅由单项研究支持,结果不精确,无法就此证据得出强结论。
- 多数证据强度低。
- 原文指出需要更多针对美洲印第安人/阿拉斯加原住民、亚裔和西班牙裔退伍军人的差异研究,并关注更多最大预期寿命差距。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Continued racial/ethnic health disparities were recently described as "the most serious and shameful health care issue of our time." Although the 2014 US Affordable Care Act-mandated national insurance coverage expansion has led to significant improvements in health care coverage and access, its effects on life expectancy are not yet known. The Veterans Health Administration (VHA), the largest US integrated health care system, has a sustained commitment to health equity that addresses all 3 stages of health disparities research: detection, understanding determinants, and reduction or elimination. Despite this, racial disparities still exist in the VHA across a wide range of clinical areas and service types. OBJECTIVES: To inform the health equity research agenda, we synthesized evidence on racial/ethnic mortality disparities in the VHA. SEARCH METHODS: Our research librarian searched MEDLINE and Cochrane Central Registry of Controlled Trials from October 2006 through February 2017 using terms for racial groups and disparities. SELECTION CRITERIA: We included studies if they compared mortality between any racial/ethnic minority and nonminority veteran groups or between different minority groups in the VHA (PROSPERO# CRD42015015974). We made study selection decisions on the basis of prespecified eligibility criteria. They were first made by 1 reviewer and checked by a second and disagreements were resolved by consensus (sequential review). DATA COLLECTION AND ANALYSIS: Two reviewers sequentially abstracted data on prespecified population, outcome, setting, and study design characteristics. Two reviewers sequentially graded the strength of evidence using prespecified criteria on the basis of 5 key domains: study limitations (study design and internal validity), consistency, directness, precision of the evidence, and reporting biases. We synthesized the evidence qualitatively by grouping studies first by racial/ethnic minority group and then by clinical area. For areas with multiple studies in the same population and outcome, we pooled their reported hazard ratios (HRs) using random effects models (StatsDirect version 2.8.0; StatsDirect Ltd., Altrincham, England). We created an evidence map using a bubble plot format to represent the evidence base in 5 dimensions: odds ratio or HR of mortality for racial/ethnic minority group versus Whites, clinical area, strength of evidence, statistical significance, and racial group. MAIN RESULTS: From 2840 citations, we included 25 studies. Studies were large (n ≥ 10 000) and involved nationally representative cohorts, and the majority were of fair quality. Most studies compared mortality between Black and White veterans and found similar or lower mortality for Black veterans. However, we found modest mortality disparities (HR or OR = 1.07, 1.52) for Black veterans with stage 4 chronic kidney disease, colon cancer, diabetes, HIV, rectal cancer, or stroke; for American Indian and Alaska Native veterans undergoing noncardiac major surgery; and for Hispanic veterans with HIV or traumatic brain injury (most low strength). AUTHOR'S CONCLUSIONS: Although the VHA's equal access health care system has reduced many racial/ethnic mortality disparities present in the private sector, our review identified mortality disparities that have persisted mainly for Black veterans in several clinical areas. However, because most mortality disparities were supported by single studies with imprecise findings, we could not draw strong conclusions about this evidence. More disparities research is needed for American Indian and Alaska Native, Asian, and Hispanic veterans overall and for more of the largest life expectancy gaps. Public Health Implications. Because of the relatively high prevalence of diabetes in Black veterans, further research to better understand and reduce this mortality disparity may be prioritized as having the greatest potential impact. However, other mortality disparities affect thousands of veterans and cannot be ignored.
引用
- Peterson K, Anderson J, Boundy E, et al. Mortality Disparities in Racial/Ethnic Minority Groups in the Veterans Health Administration: An Evidence Review and Map. Am J Public Health. 2018. PMID: 29412713. doi:10.2105/AJPH.2017.304246
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。